Time to Benefit of Sodium-Glucose Cotransporter-2 Inhibitors Among Patients With Heart Failure (2023)
Journal Article
Chen, K., Nie, Z., Shi, R., Yu, D., Wang, Q., Shao, F., …Li, C. (2023). Time to Benefit of Sodium-Glucose Cotransporter-2 Inhibitors Among Patients With Heart Failure. Jama Network Open, 6(8), Article e2330754. https://doi.org/10.1001/jamanetworkopen.2023.30754

IMPORTANCE Emerging evidence has consistently demonstrated that sodium-glucose cotransporter 2 (SGLT2) inhibitors reduce the risk of heart failure (HF) hospitalization and cardiovascular (CV) death among patients with HF. However, it remains unclear... Read More about Time to Benefit of Sodium-Glucose Cotransporter-2 Inhibitors Among Patients With Heart Failure.